Report Detail
(Post-pandemic Era)-Global Biobanking Sample Market Segment Research Report 2021
- RnM4303420 |
- 07 August, 2021 |
- Global |
- 90 Pages |
- XYZResearch |
- Medical Devices & Consumables
Summary
The global economy is expected to expand 5.6% in 2021，global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.
The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.
Regional Economic Prospects: Growth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.
The global Biobanking Sample market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to XYZResearch analysis, The segment in Biobanking Sample market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China Biobanking Sample production is XX (K Units). US market value in 2021 is about USD XX billion, and US Biobanking Sample production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe Biobanking Sample production is XX (K Units).
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Biobanking Sample Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Biobanking Sample Market?
Thermo Fisher Scientific Inc. (U.S.)
Tecan Group Ltd. (Switzerland)
Qiagen N.V. (Germany)
Hamilton Company (U.S.)
Brooks Automation (U.S.)
TTP Labtech Ltd (U.K.)
VWR Corporation (U.S.)
Promega Corporation (U.S.)
Worthington Industries [(Taylor Wharton, U.S.)]
Chart Industries (U.S.)
Becton, Dickinson and Company (U.S.)
Merck KGaA (Germany)
Micronic (Netherlands)
LVL Technologies GmbH & Co. KG (Germany)
Panasonic Healthcare Holdings Co. Ltd (Japan)
Greiner Bio One [Greiner Holding AG, Austria)]
Biokryo GmbH (Germany)
Major Type of Biobanking Sample Covered in XYZResearch report:
Blood Products
Human Tissues
Nucleic Acids
Cell Lines
Biological Fluids
Human Waste Products
Application Segments Covered in XYZResearch Market
Regenerative Medicine
Life Science Research
Clinical Research
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Biobanking Sample Market Segment Research Report 2021
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Biobanking Sample Market by Value
- 2.2.1 Global Biobanking Sample Revenue by Type
- 2.2.2 Global Biobanking Sample Market by Value (%)
- 2.3 Global Biobanking Sample Market by Production
- 2.3.1 Global Biobanking Sample Production by Type
- 2.3.2 Global Biobanking Sample Market by Production (%)
3. The Major Driver of Biobanking Sample Industry
- 3.1 Historical & Forecast Global Biobanking Sample Demand
- 3.2 Largest Application for Biobanking Sample (2017-2027)
- 3.3 The Major Downstream Company in China Market 2021
4. Global and Regional Biobanking Sample Market
- 4.1 Regional Market Size in Terms of Production & Demand (2021)
- 4.2 Regional Market Share in Terms of Revenue (2019-2027)
- 4.3 Concentration Ratio (CR5& CR10) of Biobanking Sample Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Biobanking Sample Production, Demand (2017-2027)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
6. Europe Biobanking Sample Production, Demand (2017-2027)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
7. China Biobanking Sample Production, Demand (2017-2027)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
8. Japan Biobanking Sample Production, Demand (2017-2027)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
9. India Biobanking Sample Production, Demand (2017-2027)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
10. Korea Biobanking Sample Production, Demand (2017-2027)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
11. Southeast Asia Biobanking Sample Production, Demand (2017-2027)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
12. Global Biobanking Sample Average Price Trend
- 12.1 Market Price for Each Type of Biobanking Sample in US (2017-2021)
- 12.2 Market Price for Each Type of Biobanking Sample in Europe (2017-2021)
- 12.3 Market Price for Each Type of Biobanking Sample in China (2017-2021)
- 12.4 Market Price for Each Type of Biobanking Sample in Japan (2017-2021)
- 12.5 Market Price for Each Type of Biobanking Sample in India (2017-2021)
- 12.6 Market Price for Each Type of Biobanking Sample in Korea (2017-2021)
- 12.7 Market Price for Each Type of Biobanking Sample in Southeast Asia (2017-2021)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Biobanking Sample Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Technology Trends of Biobanking Sample
14. Biobanking Sample Competitive Landscape
- 14.1 Thermo Fisher Scientific Inc. (U.S.)
- 14.1.1 Thermo Fisher Scientific Inc. (U.S.) Company Profiles
- 14.1.2 Thermo Fisher Scientific Inc. (U.S.) Product Introduction
- 14.1.3 Thermo Fisher Scientific Inc. (U.S.) Biobanking Sample Sales, Revenue (2017-2021)
- 14.1.4 Strategic initiatives
- 14.2 Tecan Group Ltd. (Switzerland)
- 14.2.1 Tecan Group Ltd. (Switzerland) Company Profiles
- 14.2.2 Tecan Group Ltd. (Switzerland) Product Introduction
- 14.2.3 Tecan Group Ltd. (Switzerland) Biobanking Sample Sales, Revenue (2017-2021)
- 14.2.4 Strategic initiatives
- 14.3 Qiagen N.V. (Germany)
- 14.3.1 Qiagen N.V. (Germany) Company Profiles
- 14.3.2 Qiagen N.V. (Germany) Product Introduction
- 14.3.3 Qiagen N.V. (Germany) Biobanking Sample Sales, Revenue (2017-2021)
- 14.3.4 Strategic initiatives
- 14.4 Hamilton Company (U.S.)
- 14.4.1 Hamilton Company (U.S.) Company Profiles
- 14.4.2 Hamilton Company (U.S.) Product Introduction
- 14.4.3 Hamilton Company (U.S.) Biobanking Sample Sales, Revenue (2017-2021)
- 14.4.4 Strategic initiatives
- 14.5 Brooks Automation (U.S.)
- 14.5.1 Brooks Automation (U.S.) Company Profiles
- 14.5.2 Brooks Automation (U.S.) Product Introduction
- 14.5.3 Brooks Automation (U.S.) Biobanking Sample Sales, Revenue (2017-2021)
- 14.5.4 Strategic initiatives
- 14.6 TTP Labtech Ltd (U.K.)
- 14.6.1 TTP Labtech Ltd (U.K.) Company Profiles
- 14.6.2 TTP Labtech Ltd (U.K.) Product Introduction
- 14.6.3 TTP Labtech Ltd (U.K.) Biobanking Sample Sales, Revenue (2017-2021)
- 14.6.4 Strategic initiatives
- 14.7 VWR Corporation (U.S.)
- 14.7.1 VWR Corporation (U.S.) Company Profiles
- 14.7.2 VWR Corporation (U.S.) Product Introduction
- 14.7.3 VWR Corporation (U.S.) Biobanking Sample Sales, Revenue (2017-2021)
- 14.7.4 Strategic initiatives
- 14.8 Promega Corporation (U.S.)
- 14.8.1 Promega Corporation (U.S.) Company Profiles
- 14.8.2 Promega Corporation (U.S.) Product Introduction
- 14.8.3 Promega Corporation (U.S.) Biobanking Sample Sales, Revenue (2017-2021)
- 14.8.4 Strategic initiatives
- 14.9 Worthington Industries [(Taylor Wharton, U.S.)]
- 14.9.1 Worthington Industries [(Taylor Wharton, U.S.)] Company Profiles
- 14.9.2 Worthington Industries [(Taylor Wharton, U.S.)] Product Introduction
- 14.9.3 Worthington Industries [(Taylor Wharton, U.S.)] Biobanking Sample Sales, Revenue (2017-2021)
- 14.9.4 Strategic initiatives
- 14.10 Chart Industries (U.S.)
- 14.10.1 Chart Industries (U.S.) Company Profiles
- 14.10.2 Chart Industries (U.S.) Product Introduction
- 14.10.3 Chart Industries (U.S.) Biobanking Sample Sales, Revenue (2017-2021)
- 14.10.4 Strategic initiatives
- 14.11 Becton, Dickinson and Company (U.S.)
- 14.12 Merck KGaA (Germany)
- 14.13 Micronic (Netherlands)
- 14.14 LVL Technologies GmbH & Co. KG (Germany)
- 14.15 Panasonic Healthcare Holdings Co. Ltd (Japan)
- 14.16 Greiner Bio One [Greiner Holding AG, Austria)]
- 14.17 Biokryo GmbH (Germany)
15. Conclusion
Summary:
Get latest Market Research Reports on Biobanking Sample. Industry analysis & Market Report on Biobanking Sample is a syndicated market report, published as (Post-pandemic Era)-Global Biobanking Sample Market Segment Research Report 2021. It is complete Research Study and Industry Analysis of Biobanking Sample market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
